Aardvark Therapeutics AARD
NASDAQ AARD
$6.82 +0.93 (+15.79%)
At close: Aug 21, 2026 · 4:00 PM EDT

Aardvark Therapeutics (AARD) Shares Outstanding (Diluted) (2024 - 2026)

Aardvark Therapeutics (AARD) Shares Outstanding (Diluted) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 255.20 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 106.00 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 64.41 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 398.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 115.80 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 138.28 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 241.70 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 217.35 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 556.90 Mn
10 Aardvark Therapeutics 147.46 Mn 73.54 Mn - 21.85 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 21.85 Mn
Mar 31, 2026 21.82 Mn
Dec 31, 2025 19.62 Mn
Sep 30, 2025 21.71 Mn
Jun 30, 2025 21.69 Mn
Mar 31, 2025 13.19 Mn
Dec 31, 2024 4.00 Mn
Sep 30, 2024 3.99 Mn
Jun 30, 2024 3.97 Mn
Mar 31, 2024 3.97 Mn